Jin Medical International Ltd. ZJYL

Full chart Compare

Set alert

3.50 USD -0.37 (-9.56%)

Regular-session close

3.50 0.00 0.00%

After hours · Nov 13, 5:24 PM ET

3.42 Day range 3.60

1.81 52-week range 5.58

YTD: -20.45%
1 year: -32.69%

6of 25 checks passed

Value 0 of 5
Growth 0 of 5
Profitability 2 of 5
Financial health 4 of 5
Dividend 0 of 5

Statements to Mar 31, 2026.

Value 0 of 5

Failed:P/E below its own 5-year median P/E 468 against a 5-year median of 74.2.
Failed:P/E under 20 P/E 468: an earnings yield of 0.2%.
Failed:Price to sales below its own 5-year median Price to sales 26.9 against a 5-year median of 9.4.
Failed:Price to book below its own 5-year median Price to book 18.4 against a 5-year median of 7.8.
Failed:Free cash flow yield above 4% Free cash flow of -3.73M is -0.7% of the market value.

Growth 0 of 5

Failed:Revenue grew over the last year Revenue of 20.7M is -12.0% on the year before.
No data:Revenue grew more than 5% a year over five years Not enough data to decide.
Failed:Earnings per share grew over the last year EPS 0.20 against 0.40 in the year before.
No data:Earnings per share grew more than 5% a year over five years Not enough data to decide.
Failed:Analysts expect higher earnings per share over the next year The average forward estimate is -100.0% on the last 12 months.

Profitability 2 of 5

Passed:Profitable over the last year Net income of 1.19M over FY 2025.
Passed:Profitable in each of the last five fiscal years A profit in 5 of the last 5 fiscal years.
Failed:Return on equity above 15% Return on equity of 4.0%.
Failed:Net margin above its 5-year average Net margin of 5.8% against a 5-year average of 12.5%.
Failed:Free cash flow is at least 80% of net income Free cash flow of -3.73M is -312.7% of net income.

Financial health 4 of 5

Passed:Short-term assets cover short-term liabilities Short-term assets of 44.6M against short-term liabilities of 22.8M.
Passed:Short-term assets cover long-term liabilities Short-term assets of 44.6M against long-term liabilities of 2.87M.
Passed:Net debt under 40% of equity More cash than debt: 30.1M of cash against 20.9M of debt.
Failed:Operating cash flow covers at least 20% of debt Operating cash flow of 2.90M is 13.9% of debt.
Passed:Operating profit covers interest at least 3 times No interest expense reported.

Dividend 0 of 5

Failed:Pays a dividend No dividend paid.
Failed:Yield above 1.5% No dividend paid.
Failed:Pays out under 75% of profit No dividend paid.
Failed:Covered by free cash flow No dividend paid.
Failed:Not cut in the last five fiscal years No dividend paid.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Short term and long term

Balance sheet · 55.8M of assets

Debt, equity and cash by year

Now: 9.20M more cash than debt

Equity
Debt
Cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

From profit to free cash flow · FY 2025

Free cash flow is -313% of net income

Returns on capital · FY 2025

4.0%

Return on equity

Below the 15% mark · Profit per dollar of shareholders’ equity
2.3%

Return on assets

Below the 5% mark · Profit per dollar of everything it owns
4.3%

Return on capital employed

Below the 10% mark · Operating profit per dollar of long-term capital

From the company’s SEC filings. The tick on each dial is a common rule-of-thumb level, not a target.